VC-backed Arcadia Biosciences goes public
Davis, California-based Arcadia Biosciences, an agricultural products developer, has raised $65.6 million for its IPO after pricing its 8.2 million shares at $8 per share. The stock began trading Friday on the NASDAQ under the ticker symbol "RKDA." Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are the lead underwriters. Arcadia’s backers include Mandala Capital Limited, CMEA Capital, BASF Venture Capital and Saints Capital.
15 May 2015•2 mins read
